| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Features |
Department of Medicine, Divisions of Diabetes (A.S.-L., S.V., T.G., J.W., H.Y.-J.) and Clinical Physiology (A.S.), and Departments of Oncology (A.-M.H.) and Radiology (J.H.), University of Helsinki, FIN-00029 HUCH, Helsinki, Finland
Address all correspondence and requests for reprints to: Hannele Yki-Järvinen, M.D., Department of Medicine, Division of Diabetes, University of Helsinki, P.O. Box 340, FIN-00029 HUCH, Helsinki, Finland. E-mail: . ykijarvi{at}helsinki.fi
Abstract
We determined whether interindividual variation in hepatic insulin sensitivity could be attributed to variation in liver fat content (LFAT) independent of obesity. We recruited 30 healthy nondiabetic men whose LFAT (determined by proton spectroscopy); intraabdominal, sc, and total (determined by magnetic resonance imaging) fat; and insulin sensitivity of endogenous glucose rate of production (Ra) and suppression of serum FFA [euglycemic insulin clamp combined with [3-3H]glucose (0–300 min); insulin infusion rate, 0.3 mU/kg·min, 120–300 min] were measured. The men were divided into groups of low (mean ± SD, 1.7 ± 0.2%) and high (10.5 ± 2.0%) LFAT based on their median fat content. The low and high LFAT groups were comparable with respect to age (44 ± 2 vs. 42 ± 2 yr), body mass index (25 ± 1 vs. 26 ± 1 kg/m2 ), waist to hip ratio (0.953 ± 0.013 vs. 0.953 ± 0.013), maximal oxygen uptake (35.6 ± 1.5 vs. 33.5 ± 1.5 ml/kg·min), and intraabdominal, sc, and total fat. The high compared with the low LFAT group had several features of insulin resistance, including fasting hyperinsulinemia (7.3 ± 0.6 vs. 5.3 ± 0.6 mU/liter; P < 0.02, high vs. low LFAT) hypertriglyceridemia (1.4 ± 0.2 vs. 0.9 ± 0.1 mmol/liter; P < 0.02), a low high density lipoprotein (HDL) cholesterol concentration (1.4 ± 0.1 vs. 1.6 ± 0.1 mmol/liter; P < 0.05), and a higher ambulatory 24-h systolic blood pressure (130 ± 3 vs. 122 ± 3 mm Hg; P < 0.05). Basal glucose Ra and serum FFA were comparable between the groups, whereas insulin suppression of glucose Ra [51 ± 8 vs. 20 ± 12 mg/m2 ·min during 240–300 min (P < 0.05) or -55 ± 7 vs. -85 ± 12% below basal (P < 0.05, high vs. low LFAT)] and of serum FFA (299 ± 33 vs. 212 ± 13 µmol/liter; 240–300 min; P < 0.02) were impaired in the high compared with the low LFAT group. Insulin stimulation of glucose Rd were comparable in the men with high LFAT (141 ± 12 mg/m2 ·min) and those with low LFAT (156 ± 14 mg/m2 ·min; P = NS).
Fat accumulation in the liver is, independent of body mass index and intraabdominal and overall obesity, characterized by several features of insulin resistance in normal weight and moderately overweight subjects.
This article has been cited by other articles:
 |
|
 |
|
  J. B. Schwimmer, P. E. Pardee, J. E. Lavine, A. K. Blumkin, and S. Cook Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease Circulation, July 15, 2008; 118(3): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. de Larranaga, S. P. Wingeyer, M. Graffigna, S. Belli, K. Bendezu, S. Alvarez, O. Levalle, and H. Fainboim Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 319 - 324. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Sevastianova, J. Sutinen, K. Kannisto, A. Hamsten, M. Ristola, and H. Yki-Jarvinen Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E85 - E91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Greco, A. Kotronen, J. Westerbacka, O. Puig, P. Arkkila, T. Kiviluoto, S. Laitinen, M. Kolak, R. M. Fisher, A. Hamsten, et al. Gene expression in human NAFLD Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1281 - G1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsunoda, N. Kobayashi, T. Ide, M. Utsumi, M. Nagasawa, and K. Murakami A novel PPAR{alpha} agonist ameliorates insulin resistance in dogs fed a high-fat diet Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E833 - E840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A. Ludovica Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis Diabetes, May 1, 2008; 57(5): 1355 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stefanovic-Racic, G. Perdomo, B. S. Mantell, I. J. Sipula, N. F. Brown, and R. M. O'Doherty A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E969 - E977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Cernkovich, J. Deng, M. C. Bond, T. P. Combs, and J. B. Harp Adipose-Specific Disruption of Signal Transducer and Activator of Transcription 3 Increases Body Weight and Adiposity Endocrinology, April 1, 2008; 149(4): 1581 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koska, N. Stefan, P. A Permana, C. Weyer, M. Sonoda, C. Bogardus, S. R Smith, D. R Joanisse, T. Funahashi, J. Krakoff, et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals Am. J. Clinical Nutrition, February 1, 2008; 87(2): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Juurinen, A. Kotronen, M. Graner, and H. Yki-Jarvinen Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 118 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kotronen and H. Yki-Jarvinen Fatty Liver: A Novel Component of the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden Diabetes and Obesity: Part 1 Diabetes Care, December 1, 2007; 30(12): 3145 - 3151. [Full Text] [PDF]
|
|
|
|
|
|
D. P.Y. Koonen, R. L. Jacobs, M. Febbraio, M. E. Young, C.-L. M. Soltys, H. Ong, D. E. Vance, and J. R.B. Dyck Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity Diabetes, December 1, 2007; 56(12): 2863 - 2871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kotronen, S. Vehkavaara, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen Effect of liver fat on insulin clearance Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1709 - E1715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Hwang, D. T. Stein, N. Barzilai, M.-H. Cui, J. Tonelli, P. Kishore, and M. Hawkins Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1663 - E1669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shibata, Y. Kihara, M. Taguchi, M. Tashiro, and M. Otsuki Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men Diabetes Care, November 1, 2007; 30(11): 2940 - 2944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Janiszewski, K. C. Oeffinger, T. S. Church, A. L. Dunn, D. A. Eshelman, R. G. Victor, S. Brooks, A. J. Turoff, E. Sinclair, J. C. Murray, et al. Abdominal Obesity, Liver Fat, and Muscle Composition in Survivors of Childhood Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3816 - 3821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kumazawa, M. Kobayashi, F. Io, T. Kawai, M. Nishimura, T. Ohno, and F. Horio Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet J. Lipid Res., September 1, 2007; 48(9): 2039 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kotronen, J. Westerbacka, R. Bergholm, K. H. Pietilainen, and H. Yki-Jarvinen Liver Fat in the Metabolic Syndrome J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3490 - 3497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Choi, D. B. Savage, A. Kulkarni, X. X. Yu, Z.-X. Liu, K. Morino, S. Kim, A. Distefano, V. T. Samuel, S. Neschen, et al. Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance J. Biol. Chem., August 3, 2007; 282(31): 22678 - 22688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Matikainen, S. Manttari, J. Westerbacka, S. Vehkavaara, N. Lundbom, H. Yki-Jarvinen, and M.-R. Taskinen Postprandial Lipemia Associates with Liver Fat Content J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3052 - 3059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sato, Y. Tamura, H. Watada, N. Kumashiro, Y. Igarashi, H. Uchino, T. Maehara, S. Kyogoku, S. Sunayama, H. Sato, et al. Effects of Diet-Induced Moderate Weight Reduction on Intrahepatic and Intramyocellular Triglycerides and Glucose Metabolism in Obese Subjects J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3326 - 3329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Sung, M. C. Ryan, B. S. Kim, Y. K. Cho, B. I. Kim, and G. M. Reaven Relationships Between Estimates of Adiposity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in a Large Group of Nondiabetic Korean Adults Diabetes Care, August 1, 2007; 30(8): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kolak, J. Westerbacka, V. R. Velagapudi, D. Wagsater, L. Yetukuri, J. Makkonen, A. Rissanen, A.-M. Hakkinen, M. Lindell, R. Bergholm, et al. Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity Diabetes, August 1, 2007; 56(8): 1960 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pagliassotti, Y. Wei, and D. Wang Insulin Protects Liver Cells from Saturated Fatty Acid-Induced Apoptosis via Inhibition of c-Jun NH2 Terminal Kinase Activity Endocrinology, July 1, 2007; 148(7): 3338 - 3345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Klein, D. B. Allison, S. B. Heymsfield, D. E. Kelley, R. L. Leibel, C. Nonas, and R. Kahn Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association Diabetes Care, June 1, 2007; 30(6): 1647 - 1652. [Full Text] [PDF]
|
|
|
|
|
|
S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jakobsen, T Berentzen, T. Sorensen, and K Overvad Abdominal Obesity and Fatty Liver Epidemiol. Rev., May 2, 2007; (2007) mxm002v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Klein, D. B Allison, S. B Heymsfield, D. E Kelley, R. L Leibel, C. Nonas, and R. Kahn Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1197 - 1202. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Ryan, F. Abbasi, C. Lamendola, S. Carter, and T. L. McLaughlin Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults Diabetes Care, May 1, 2007; 30(5): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Savage, K. F. Petersen, and G. I. Shulman Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance Physiol Rev, April 1, 2007; 87(2): 507 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Perseghin, G. Lattuada, F. De Cobelli, F. Ragogna, G. Ntali, A. Esposito, E. Belloni, T. Canu, I. Terruzzi, P. Scifo, et al. Habitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans Diabetes Care, March 1, 2007; 30(3): 683 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Juurinen, M. Tiikkainen, A.-M. Hakkinen, A. Hakkarainen, and H. Yki-Jarvinen Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E829 - E835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qu, D. Su, J. Altomonte, A. Kamagate, J. He, G. Perdomo, T. Tse, Y. Jiang, and H. H. Dong PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1 Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E421 - E434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fishman, R. H. Muzumdar, G. Atzmon, X. Ma, X. Yang, F. H. Einstein, and N. Barzilai Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo FASEB J, January 1, 2007; 21(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Utzschneider and S. E. Kahn The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4753 - 4761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Perseghin, G. Lattuada, F. De Cobelli, G. Ntali, A. Esposito, A. Burska, E. Belloni, T. Canu, F. Ragogna, P. Scifo, et al. Serum Resistin and Hepatic Fat Content in Nondiabetic Individuals J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5122 - 5125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ha, M.-J. Kim, B.-K. Choi, J.-J. Rho, D.-J. Oh, T.-H. Rho, K.-H. Kim, H. J. Lee, D.-H. Shin, S. V. Yim, et al. Positive Association of Obesity with Single Nucleotide Polymorphisms of Syndecan 3 in the Korean Population J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5095 - 5099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Petersen, S. Dufour, J. Feng, D. Befroy, J. Dziura, C. D. Man, C. Cobelli, and G. I. Shulman Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men PNAS, November 28, 2006; 103(48): 18273 - 18277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Burgert, S. E. Taksali, J. Dziura, T. R. Goodman, C. W. Yeckel, X. Papademetris, R. T. Constable, R. Weiss, W. V. Tamborlane, M. Savoye, et al. Alanine Aminotransferase Levels and Fatty Liver in Childhood Obesity: Associations with Insulin Resistance, Adiponectin, and Visceral Fat J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4287 - 4294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Perseghin, R. Bonfanti, S. Magni, G. Lattuada, F. De Cobelli, T. Canu, A. Esposito, P. Scifo, G. Ntali, F. Costantino, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E697 - E703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Koutsari and M. D. Jensen Thematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity J. Lipid Res., August 1, 2006; 47(8): 1643 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G.S. Toledo, A. D. Sniderman, and D. E. Kelley Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes Diabetes Care, August 1, 2006; 29(8): 1845 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Raubenheimer, M. J. Nyirenda, and B. R. Walker A Choline-Deficient Diet Exacerbates Fatty Liver but Attenuates Insulin Resistance and Glucose Intolerance in Mice Fed a High-Fat Diet. Diabetes, July 1, 2006; 55(7): 2015 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Chang, B. Taouli, N. Salibi, E. M. Hecht, D. G. Chin, and V. S. Lee Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance. Am. J. Roentgenol., July 1, 2006; 187(1): W103 - W106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A Walz, L. Harndahl, N. Wierup, E. Zmuda-Trzebiatowska, F. Svennelid, V. C Manganiello, T. Ploug, F. Sundler, E. Degerman, B. Ahren, et al. Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B. J. Endocrinol., June 1, 2006; 189(3): 629 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Larson-Meyer, L. K. Heilbronn, L. M. Redman, B. R. Newcomer, M. I. Frisard, S. Anton, S. R. Smith, A. Alfonso, E. Ravussin, and the Pennington CALERIE Team Effect of Calorie Restriction With or Without Exercise on Insulin Sensitivity, {beta}-Cell Function, Fat Cell Size, and Ectopic Lipid in Overweight Subjects. Diabetes Care, June 1, 2006; 29(6): 1337 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin, Z. Chen, P. Yue, M. R. Averna, R. E. Ostlund Jr., M. A. Watson, and G. Schonfeld A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1170 - G1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Buemann, A. Astrup, O. Pedersen, E. Black, C. Holst, S. Toubro, S. Echwald, J. J. Holst, C. Rasmussen, and T. I. A. Sorensen Possible Role of Adiponectin and Insulin Sensitivity in Mediating the Favorable Effects of Lower Body Fat Mass on Blood Lipids J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1698 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Linden, L. William-Olsson, A. Ahnmark, K. Ekroos, C. Hallberg, H. P. Sjogren, B. Becker, L. Svensson, J. C. Clapham, J. Oscarsson, et al. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation FASEB J, March 1, 2006; 20(3): 434 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Franckhauser, S. Munoz, I. Elias, T. Ferre, and F. Bosch Adipose Overexpression of Phosphoenolpyruvate Carboxykinase Leads to High Susceptibility to Diet-Induced Insulin Resistance and Obesity Diabetes, February 1, 2006; 55(2): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Snijder, R. van Dam, M Visser, and J. Seidell What aspects of body fat are particularly hazardous and how do we measure them? Int. J. Epidemiol., February 1, 2006; 35(1): 83 - 92. [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr, and S. M. Haffner Liver Markers and Development of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Diabetes, November 1, 2005; 54(11): 3140 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Grefhorst, J. Hoekstra, T. G. J. Derks, D. M. Ouwens, J. F. W. Baller, R. Havinga, L. M. Havekes, J. A. Romijn, and F. Kuipers Acute hepatic steatosis in mice by blocking {beta}-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G592 - G598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin, P. Yue, Y. Xie, N. O. Davidson, N. Sakata, R. E. Ostlund Jr., Z. Chen, and G. Schonfeld Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G146 - G152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tamura, Y. Tanaka, F. Sato, J. B. Choi, H. Watada, M. Niwa, J. Kinoshita, A. Ooka, N. Kumashiro, Y. Igarashi, et al. Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3191 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Watts, V. P. Manchem, T. A. Leedom, A. L. Rivard, R. A. McKay, D. Bao, T. Neroladakis, B. P. Monia, D. M. Bodenmiller, J. X.-C. Cao, et al. Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism Diabetes, June 1, 2005; 54(6): 1846 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
